Skandinaviska Enskilda Banken AB publ Sells 4,934 Shares of Waters Corporation $WAT

Skandinaviska Enskilda Banken AB publ reduced its stake in shares of Waters Corporation (NYSE:WAT) by 30.9% in the third quarter, HoldingsChannel.com reports. The fund owned 11,009 shares of the medical instruments supplier’s stock after selling 4,934 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Waters were worth $3,301,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Root Financial Partners LLC purchased a new stake in Waters during the third quarter valued at about $26,000. Hantz Financial Services Inc. boosted its holdings in shares of Waters by 115.4% in the 3rd quarter. Hantz Financial Services Inc. now owns 112 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 60 shares in the last quarter. CYBER HORNET ETFs LLC bought a new position in shares of Waters during the 2nd quarter valued at about $53,000. Versant Capital Management Inc raised its holdings in shares of Waters by 510.3% during the 3rd quarter. Versant Capital Management Inc now owns 177 shares of the medical instruments supplier’s stock valued at $53,000 after buying an additional 148 shares in the last quarter. Finally, Quent Capital LLC purchased a new position in shares of Waters during the 3rd quarter valued at about $59,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

WAT has been the subject of several research reports. UBS Group cut their target price on Waters from $395.00 to $370.00 and set a “neutral” rating for the company in a research note on Tuesday, February 10th. Barclays assumed coverage on shares of Waters in a research note on Tuesday, February 10th. They issued an “overweight” rating and a $400.00 price objective for the company. William Blair initiated coverage on shares of Waters in a report on Monday, January 5th. They set an “outperform” rating on the stock. HSBC initiated coverage on shares of Waters in a research note on Tuesday, January 27th. They issued a “buy” rating and a $460.00 price target for the company. Finally, Wall Street Zen cut Waters from a “buy” rating to a “hold” rating in a research note on Sunday, February 8th. Two research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $397.68.

Waters Trading Up 1.4%

Shares of WAT opened at $333.41 on Friday. The stock has a market capitalization of $19.85 billion, a P/E ratio of 30.96, a PEG ratio of 2.26 and a beta of 1.18. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $414.15. The company has a quick ratio of 1.01, a current ratio of 1.41 and a debt-to-equity ratio of 0.41. The firm has a fifty day simple moving average of $374.36 and a two-hundred day simple moving average of $348.68.

Waters (NYSE:WAT) last issued its quarterly earnings data on Monday, February 9th. The medical instruments supplier reported $4.53 EPS for the quarter, beating the consensus estimate of $4.50 by $0.03. The firm had revenue of $932.36 million during the quarter, compared to the consensus estimate of $928.17 million. Waters had a net margin of 20.30% and a return on equity of 34.79%. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.10 earnings per share. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. On average, research analysts anticipate that Waters Corporation will post 12.86 EPS for the current year.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.